Dr. Chapa’s OBGYN Clinical Pearls
Remdesivir for COVID-19
7 min•3 maj 2020
Om avsnittet
On May 1, 2020, the FDA authorized the emergency use of Remdesivir for COVID-19. This was based on a preliminary analysis of an NIH clinical trial. However, information is still lacking on safety and efficacy in a larger study population. In this session, we will review the known mechanism of action of this novel antiviral medication and limitations of data.
Dr. Chapa’s OBGYN Clinical Pearls med Dr. Chapa’s Clinical Pearls finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.